NEWS: "Hot Off the Press"
- ZenaTech’s ZenaDrone Subsidiary Commences Testing of Its IQ Square Drone for Public Safety and Emergency Response Applications, a USD $5.5 Billion Market
- RTK vs PPK in Drone Mapping: Key Differences Explained
- Alpha Modus Declares Patent Minefield: Allerin Steps on All Ten
- Alpha Modus Files Patent Infringement Lawsuit Against MNTN, Inc. in the Western District of Texas
- ZenaTech Announces the Acquisition of Lescure Engineers Inc. Expanding Drone as a Service (DaaS) to California’s Precision Agriculture and Viticulture Markets
- Information Security Strategies That Actually Work Because They’re Built for Change
- ZenaTech Signs Offer to Acquire a Warehouse and Inventory Management Company with Established Long-Term US Defense Government Contracts, Accelerating DaaS Expansion on the East Coast
- Alpha Modus to Present at H.C. Wainwright 27th Annual Global Investment Conference
- Drone Mapping: The Ultimate Guide in 2025
- Affluence Corporation Issues Shareholder Letter Highlighting Post-Merger Financial Performance, Restructuring Progress, and Uplisting Strategy
- Alpha Modus Files Patent Infringement Lawsuit Against Creative Realities, Inc., Reinforcing Its Leadership in AI-Driven Retail Innovation
- Alpha Modus Strikes Kroger Again: Major Patent Infringement Lawsuit Filed Targeting Kroger’s Digital Retail Ecosystem
- Affluence Corporation Strengthens Acquisition Strategy to Drive Scalable Growth
- Smart City Success in Malaysia: A Reproducible Model Powered by thethings.iO – MTi’s IoT Platform
- What Are Managed IT Services?
- AI Chatbots: A Transformative Market Set to Soar Beyond 2026
- Affluence Corporation Issues Shareholder Letter Highlighting Strategic Growth, U.S. Expansion and Financial Reset
- Affluence Corporation Reports Over €6.4 Million in Signed Contracts for H1 2025, Confirms Positive Momentum and Strategic Focus on U.S. Expansion
- Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
- Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by New to The Street TV.
